NeoGenomics, Inc. (NEO)

NasdaqCM Currently up 0.12 (+0.86%) in today's trading session

2 members of Congress have disclosed 4 trades in NeoGenomics, Inc. (NEO) via STOCK Act filings. The most recent disclosure was a purchase by Gilbert Cisneros on 7 May 2025. The most active traders have been Dwight Evans (3) and Gilbert Cisneros (1). Aggregate disclosed activity totals roughly $24K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

NeoGenomics, Inc. is currently trading at $14.13, positioned at 87% of its 52-week range ($4.72 – $15.57).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$14.13
24h Change
+0.12 (+0.86%)
52 Week Range
$4.72$15.57
View on NASDAQ

NeoGenomics, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for NEO

Select to highlight on chart
3 transactions
Compliance: 75%
Gilbert Cisneros7 May 20256 Jun 2025PurchaseStock$1,001 - $15,000N/A
Dwight Evans30 Mar 202225 Apr 2022SaleStock$1,001 - $15,000N/A
Dwight Evans2 Mar 202023 Apr 2020PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$368.32M

Volume

1.15M

Beta

1.74

P/E Ratio

108.69

Fundamentals

EPS

$0.13

Div. Yield

2.83%

Open

$13.66

Day Range

$13.66 — $14.62

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
Country
US
CEO
Anthony Zook
IPO Date
2004-03-16

NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical S...

Earnings

Next Report

Q2 2026

28 Jul

EPS Est.

$0.03

Rev. Est.

$196.9M

Days Until

5

Recent Quarters

Q1 202628 Apr
EPS$0.01
Beat 73.0%
Q4 202517 Feb
EPS$0.06
Beat 50.0%
Q3 202528 Oct
EPS$0.03
Beat 50.0%
Q2 202529 Jul
EPS$0.03
Beat 0.0%
Q1 202529 Apr
EPS$-0.08
Miss 300.0%
Q4 202418 Feb
EPS$0.04
Beat 33.3%
Q3 20245 Nov
EPS$0.05
Beat 316.7%
Q2 202429 Jul
EPS$0.03
Beat 880.4%
Q1 202430 Apr
EPS$-0.02
Miss 59.2%
Q4 202320 Feb
EPS$0.03
Beat 220.5%
Q3 20236 Nov
EPS$-0.06
Beat 14.3%
Q2 20238 Aug
EPS$-0.05
Beat 50.0%
Q1 20238 May
EPS$-0.09
Beat 35.7%
Q4 202223 Feb
EPS$-0.06
Beat 60.0%
Q3 20228 Nov
EPS$-0.14
Beat 26.3%
Q2 20229 Aug
EPS$-0.16
Beat 27.3%
Q1 202227 Apr
EPS$-0.20
Beat 13.0%
Q4 202123 Feb
EPS$-0.14
Miss 7.7%
Q3 20214 Nov
EPS$-0.08
Beat 0.0%
Q2 20216 Aug
EPS$-0.01
Beat 80.0%
Q1 20215 May
EPS$-0.04
Miss 466.6%
Q4 202024 Feb
EPS$0.14
Beat 133.3%
Q3 202027 Oct
EPS$0.06
Beat 57.9%
Q2 202028 Jul
EPS$-0.04
Beat 55.6%
Q1 202028 Apr
EPS$-0.02
Miss 199.8%
Q4 201927 Feb
EPS$0.10
Beat 42.9%
Q3 201929 Oct
EPS$0.07
Beat 16.7%
Q2 201930 Jul
EPS$0.07
Beat 0.0%
Q1 201930 Apr
EPS$0.07
Beat 40.0%
Q4 201819 Feb
EPS$0.06
Beat 20.0%
Q3 201830 Oct
EPS$0.05
Beat 110.5%
Q2 201824 Jul
EPS$0.05
Beat 20.0%
Q1 20181 May
EPS$0.04
Beat 30.4%
Q4 201721 Feb
EPS$0.05
Beat 30.3%
Q3 201725 Oct
EPS$0.01
Miss 42.9%
Q2 201725 Jul
EPS$0.04
Beat 20.0%
Q1 201726 Apr
EPS$0.03
Beat 7.1%
Q4 201622 Feb
EPS$0.05
Beat 72.4%
Q3 201626 Oct
EPS$0.04
Beat 44.0%
Q2 201626 Jul
EPS$0.04
Beat 40.0%
Q1 201627 Apr
EPS$0.03
Beat 130.0%
Q4 20151 Mar
EPS$0.05
Beat 287.5%
Q3 201529 Oct
EPS$-0.00
Q2 201523 Jul
EPS$-0.00
Miss 99.3%
Q1 201528 Apr
EPS$-0.01
Miss 33.3%
Q4 201424 Feb
EPS$0.02
Beat 140.1%
Q3 201430 Oct
EPS$0.01
Beat 220.5%
Q2 201417 Jul
EPS$0.01
Beat 100.0%
Q1 201423 Apr
EPS$0.00
Q4 201319 Feb
EPS$0.02
Beat 33.3%
Q3 201323 Oct
EPS$0.02
Beat 100.0%
Q2 201331 Jul
EPS$0.01
Q1 201325 Apr
EPS$0.00
Q4 201214 Feb
EPS$-0.00
Miss 100.0%
Q3 201231 Oct
EPS$-0.02
Miss 60.0%
Q2 201219 Jul
EPS$0.01
Miss 33.3%
Q1 201225 Apr
EPS$0.01
Beat 100.0%
Q4 201116 Feb
EPS$0.00
Q3 201119 Oct
EPS$-0.00
Miss 100.0%
Q2 201120 Jul
EPS$-0.01
Miss 33.3%
Q1 201121 Apr
EPS$-0.02
Miss 100.0%
Q4 201010 Feb
EPS$-0.01
Miss 50.0%
Q3 201028 Oct
EPS$-0.03
Miss 200.0%
Q2 201029 Jul
EPS$-0.03
Miss 20.0%
Q1 201029 Apr
EPS$-0.02
Beat 0.0%
Q4 200925 Feb
EPS$-0.04
Beat 0.0%
Q3 200929 Oct
EPS$-0.02
Miss 199.8%
Q2 200928 Jul
EPS$0.00
Q1 200923 Apr
EPS$0.00
Q4 20085 Mar
EPS$-0.03
Miss 400.0%
Q3 20086 Nov
EPS$-0.01
Miss 300.6%
Q2 200831 Jul
EPS$0.00
Q1 20087 May
EPS$-0.01
Beat 15.5%
Q1 200814 Apr
EPS$-0.01
Q4 200718 Mar
EPS$-0.05
Miss 400.0%
Q3 200714 Nov
EPS$-0.02
Miss 100.0%
Q2 20072 Aug
EPS$-0.03
Miss 200.0%
Q1 20079 May
EPS$-0.02
Miss 56.8%
Q3 200617 Nov
EPS$0.00
Q2 200619 Jul
EPS$0.01
Q1 20069 May
EPS$0.00
Q4 200531 Mar
EPS$-0.02
Q3 20051 Nov
EPS$-0.01
Q2 200511 Aug
EPS$-0.01
Q1 200529 Apr
EPS$-0.01
Q1 200515 Apr
EPS$-0.01
Q3 200412 Nov
EPS$-0.01
Q2 200423 Jul
EPS$-0.01
Q1 200417 May
EPS$-0.01
Q4 200324 Feb
EPS$-0.01
Q3 200314 Nov
EPS$-0.01
Q2 200313 Aug
EPS$-0.01
Q1 200320 Jun
EPS$-0.03
Q1 200319 May
EPS$0.34
Q3 200220 Nov
EPS$-0.17
Q2 200214 Aug
EPS$-0.18
Q1 200223 May
EPS$-0.14
Q1 200221 May
EPS$-6.11
Q3 200119 Nov
EPS$-0.12
Q2 200120 Aug
EPS$-0.20
Q1 200115 May
EPS$-0.35
Q1 200116 Apr
EPS$-1.28
Q3 200014 Nov
EPS$-1.90
Q2 200021 Sept
EPS$-1.19
Q1 200022 May
EPS$-0.23
Q2 199919 Aug
EPS$-0.24

1 politician traded within 30 days

Dividends

Dividend History

17 Dec 2020
Amount $0.4000

Stock Splits

Split History

16 Apr 2003Reverse Split
Ratio1:100
17 Nov 2000Stock Split
Ratio4:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

AAPL

Apple Inc.

22
$320.87-5.02 (-1.54%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

WBI

WaterBridge Infrastructure LLC

17
$35.51-0.70 (-1.93%)
Energy
Held by same politician
1 politician
View Stock

SPY

State Street SPDR S&P 500 ETF Trust

17
$737.20-10.21 (-1.37%)
Financial Services
Held by same politician
1 politician
View Stock

Frequently Asked Questions about NEO

Which members of Congress have traded NEO?
2 members of Congress have disclosed 4 trades in NeoGenomics, Inc. (NEO) under the STOCK Act. The most active traders are Dwight Evans and Gilbert Cisneros.
When was NEO most recently disclosed by Congress?
The most recent NEO disclosure was a purchase by Gilbert Cisneros on 7 May 2025.
What is the total disclosed congressional trading volume for NEO?
Members of Congress have disclosed approximately $24K in NEO purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in NEO?
This NEO page updates as soon as new STOCK Act disclosures are filed for NeoGenomics, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.